Fundamental Analysis
31 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -401.3% | -73.1% | 2 / 3 | +23.9% | -16.24 pp | -14.61 pp | -13.9% | 1.04 | — | 4,5 | +23,9% | −0,5 | −401,3% | — | -10.65 | — |
| Pts | 0 | 0 | 8 | 12 | 0 | 0 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 5.000 (close price on 2026-10-14)EPS (TTM): −198,9
Financial charts
1.Revenue & growth
VND bn4,43Q2/26
1.Revenue & growth
VND bn4,43Q2/26
2.Profit & growth
VND bn-2,74Q2/26
3.Profit mix (Penman)
VND bn-6,98Q2/26
4.Margins & cost structure
%2.7%Q2/26
5.Returns & cash cycle
% · days-6.6%Q2/26
6.Earnings quality & cash
VND bn8,40Q2/26
7.Asset structure
VND bn90,7Q2/26
8.Funding & debt health
VND bn · times90,7Q2/26
9.Revenue backlog
VND bn8,61Q2/26
10.Valuation
times · %-25,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-116Q2/26
Adjusted EPS growth, latest quarter
-1883%
Average adjusted EPS growth, 3 quarters
-1883%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26